
The Swiss biopharmaceutical firm’s shares surged in after-hours buying and selling after it stated the FDA authorised its Optune Pax product.
Source link


The Swiss biopharmaceutical firm’s shares surged in after-hours buying and selling after it stated the FDA authorised its Optune Pax product.
Source link
:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)



Recent Comments